Track the Ambu A/S stock price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares trade on DK DK, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Ambu A/S has recorded 228 reports. Market capitalisation: €17.9bn. The latest transaction was reported on 9 June 2026 (Purchase). Among the most active insiders: Unknown. The full history is openly available.
228
Insider Decl.
0
Thresholds
€6m
13 ops.
Buy Volume
€385m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ambu A/S Buy (bullish), based on 8 analysts. Average price target: DKK 87.30.
38Σ signal
Buys €6m€385m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,694 of 26,127 companies
52.7
score / 100
Value
41
Quality
65
FCF yld2.9%
Earn yld1.3%
EV/EBITDA18.1x
ROE7.9%
Gross mgn59%
Net mgn4.4%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
39,000 shares@ DKK 190.080.0029% mcap0.3% of flowShareNasdaq CopenhagenDK:976293
Ideal exit: 3 Sept 2021 (T+270)
25 of 228 declarations
About Ambu A/S
Ambu A/S is a Danish company that specializes in the development and manufacturing of medical devices. It primarily focuses on products for resuscitation, anesthesia, and patient monitoring.